ZyVersa Therapeutics Inc.

NASDAQ: ZVSA · Real-Time Price · USD
0.31
-0.24 (-43.53%)
At close: Jul 16, 2025, 3:59 PM

ZyVersa Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
1.53M 3.14M 5.9M 328.58K
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
235.71K 98.48K 46.66K 286.66K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
184.87K 215.46K 460.35K 483.2K
Total Current Assets
1.72M 3.35M 6.36M 811.78K
Property-Plant & Equipment
n/a 14.77K 115.7K 27.73K
Goodwill & Intangibles
18.65M 18.65M 111.98M n/a
Total Long-Term Assets
18.88M 18.76M 112.14M 314.39K
Total Assets
20.6M 22.11M 118.51M 1.13M
Account Payables
9.34M 8.43M 6.03M 2M
Deferred Revenue
n/a n/a n/a 765.68K
Short-Term Debt
n/a n/a 108.76K 9.15M
Other Current Liabilities
854.7K 1.09M 1.36M 2.46M
Total Current Liabilities
11.23M 10.19M 8.19M 13.63M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
851.66K 844.91K 10.32M n/a
Total Liabilities
12.08M 11.04M 18.51M 13.63M
Total Debt
n/a 8.66K 108.76K 9.15M
Common Stock
251.00 405.00 902.00 242.00
Retained Earnings
-112.63B -103.22M -4.92M -52.9M
Comprehensive Income
n/a n/a n/a -331.33K
Shareholders Equity
8.52B 11.07M 99.99M -12.5M
Total Investments
1.53B n/a n/a n/a